Category Archives: Business and Investments

Latest From Business and Investments

A Better Way To Ship Temperature-Sensitive Materials

Dewar copy

With the business needs of the life science industry in mind, FedEx® has expanded its shipping service portfolio to include Deep Frozen Shipping Solution. Participants of BIO Business Solutions® can now access a discounted, non-hazardous, liquid nitrogen dry vapor technology with end-to-end shipment monitoring. This safe and cost-effective option for the shipment of expensive, temperature-sensitive biogenetics and biomaterials, has a 10-day holding time (below -150oC) that allows samples and substances to be mailed globally without having to worry about sublimation or Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BioNJ Streamlines Clinical Trials Agreement Process

bionj3

Biotechnology companies face monumental challenges – from containing R&D costs to managing sales and marketing to compliance with regulatory bodies. Biotech startups often operate with just a few employees, all of whom tend to pull double duty, both in the lab and front office. With that in mind, BioNJ has produced a free document available to companies (not just New Jersey-based ) interested in streamlining the often time-consuming process of negotiating clinical trial agreements. The Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Post-Con BIO CEO Company Snapshot: Immunovaccine

Immunovaccine-logo-PMS

A few weeks ago, the BIO CEO & Investor Conference concluded in New York City. With a 30% increase in One-on-One Partnering meetings and sold out company presentations, industry execs gathered to do business, and hear the latest from innovative companies. As a precursor to the event, the company snapshot campaign highlighted a few of the companies who would be participating onsite. This year, the snapshot feature concludes with an interview from Marc Mansour, Ph.D., Chief Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Participate in the 11th Annual Biopharmaceutical Manufacturing Report and Survey

Participate in the biopharmaceutical manufacturing industry’s most in-depth, global study: 11th Annual Biopharmaceutical Manufacturing Report and Survey. Your input is more important than ever, as BioPlan Associates benchmarks global and regional trends affecting the industry. You will receive a free summary of the results of the study as well as BioPlan’s 159 Key Industry Facts White Paper. For each completed survey BioPlan will donate $10 (up to $10,000) to global health charities. The survey takes Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

The Economist – Biotechnology: Fever Rising

The-Economist-115x76

After speaking with several attendees and speakers at last week’s BIO CEO & Investor Conference, the Economist featured an article this week about the strong performance of biotech equities recently: AS INVESTORS and executives crammed into a New York ballroom for a conference held this week by the Biotechnology Industry Organisation, the mood was jittery. The previous week eight biotech firms had launched initial public offerings in America, together raising more than $500m. In a discussion Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , ,